DI STASO, ROSSANA
DI STASO, ROSSANA
DIMEC - DIPARTIMENTO DI SCIENZE MEDICHE E CHIRURGICHE
Dottorandi
Economic evaluation of anti-CD19 CAR T-cell pathway for large B-cell lymphomas in the real-life setting: the experience of an Italian hub center in the first three years of activity
2024 Di Staso, Rossana; Casadei, Beatrice; Gentilini, Marianna; Guadagnuolo, Serafina; Pellegrini, Cinzia; Broccoli, Alessandro; Gori, Davide; Masetti, Riccardo; Stefoni, Vittorio; Bonifazi, Francesca; Zinzani, Pier Luigi; Argnani, Lisa
Is CAR T a drug or a therapeutic pathway? Intention to treat versus per protocol analysis of real world studies of CAR-T cell therapy in relapsed refractory diffuse large B cell lymphoma
2024 Di Staso, Rossana; Casadei, Beatrice; Locke, Frederick L.; Jain, Michael; Voorhees, Timothy J.; Kittai, Adam S.; Bastos-Oreiro, Mariana; Gutiérrez, Antonio; Martin Garcia-Sancho, Alejandro; Terol, Maria Jose; Mead, Monica; Maranzano, Michael J.; Iacoboni, Gloria; Barba, Pere; Kwon, Mi; Bailen, Rebeca; Reguera-Ortega, Juan Luis; Mian, Agrima; Hill, Brian; Bachy, Emmanuel; Morschhauser, Franck; Houot, Roch; Thieblemont, Catherine; Le Gouill, Steven; Masetti, Riccardo; Gori, Davide; Broccoli, Alessandro; Zinzani, Pier Luigi; Argnani, Lisa
Role of age as eligibility criterion for ECMO in patients with ARDS: meta-regression analysis
2024 Tonetti T.; Di Staso R.; Bambini L.; Bordini M.; D'Albo R.; Nocera D.; Sbaraini Zernini I.; Turriziani I.; Mascia L.; Rucci P.; Ranieri V.M.
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| Economic evaluation of anti-CD19 CAR T-cell pathway for large B-cell lymphomas in the real-life setting: the experience of an Italian hub center in the first three years of activity | Di Staso, Rossana; Casadei, Beatrice; Gentilini, Marianna; Guadagnuolo, Serafina; Pellegrini, Cin...zia; Broccoli, Alessandro; Gori, Davide; Masetti, Riccardo; Stefoni, Vittorio; Bonifazi, Francesca; Zinzani, Pier Luigi; Argnani, Lisa | 2024-01-01 | ANNALS OF HEMATOLOGY | - | 1.01 Articolo in rivista | Economic evaluation of anti‑CD19 CAR T‑cell.pdf; 277_2024_5766_MOESM1_ESM.docx |
| Is CAR T a drug or a therapeutic pathway? Intention to treat versus per protocol analysis of real world studies of CAR-T cell therapy in relapsed refractory diffuse large B cell lymphoma | Di Staso, Rossana; Casadei, Beatrice; Locke, Frederick L.; Jain, Michael; Voorhees, Timothy J.; K...ittai, Adam S.; Bastos-Oreiro, Mariana; Gutiérrez, Antonio; Martin Garcia-Sancho, Alejandro; Terol, Maria Jose; Mead, Monica; Maranzano, Michael J.; Iacoboni, Gloria; Barba, Pere; Kwon, Mi; Bailen, Rebeca; Reguera-Ortega, Juan Luis; Mian, Agrima; Hill, Brian; Bachy, Emmanuel; Morschhauser, Franck; Houot, Roch; Thieblemont, Catherine; Le Gouill, Steven; Masetti, Riccardo; Gori, Davide; Broccoli, Alessandro; Zinzani, Pier Luigi; Argnani, Lisa | 2024-01-01 | BLOOD CANCER JOURNAL | - | 1.01 Articolo in rivista | 41408_2024_Article_1183.pdf |
| Role of age as eligibility criterion for ECMO in patients with ARDS: meta-regression analysis | Tonetti T.; Di Staso R.; Bambini L.; Bordini M.; D'Albo R.; Nocera D.; Sbaraini Zernini I.; Turri...ziani I.; Mascia L.; Rucci P.; Ranieri V.M. | 2024-01-01 | CRITICAL CARE | - | 1.01 Articolo in rivista | Tonetti_2024.pdf; 13054_2024_5074_MOESM1_ESM.docx |